BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced that The Wall Street Analyst conducted an audio interview yesterday with the Company's Chief Executive Officer Alon Natanson.
http://www.biospace.com/news_story.aspx?StoryID=297847&full=1
http://www.biospace.com/news_story.aspx?StoryID=297847&full=1
No comments:
Post a Comment